FDA Approved: INVEGA SUSTENNA — Original Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

This FDA entry records the original NDA approval of Invega Sustenna (paliperidone palmitate) by Janssen Pharmaceuticals for the treatment of schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• INVEGA SUSTENNA (PALIPERIDONE PALMITATE)

Snippet

ORIG AP for INVEGA SUSTENNA (PALIPERIDONE PALMITATE)